| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.2 |
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.2 |
| mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | 0.072 | 0.2 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | BMS-509744 | GDSC1000 | pan-cancer | AAC | -0.071 | 0.2 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.2 |
| mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | -0.062 | 0.2 |
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.2 |